Publications by authors named "James Dropinski"

Claim this Profile
R
Ruthenium-Catalyzed Enantioselective Hydrogenation of Hydrazones.
Christopher H Schuster, James F Dropinski, Michael Shevlin, Hongming Li, Song Chen

Org Lett· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase.
Danqing Feng, Tesfaye Biftu, F Anthony Romero, Ahmet Kekec, James Dropinski

ACS Med Chem Lett· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxyfunctionalization of the Remote C-H Bonds of Aliphatic Amines by Decatungstate Photocatalysis.
Danielle M Schultz, François Lévesque, Daniel A DiRocco, Mikhail Reibarkh, Yining Ji, James F Dropinski

Angew Chem Int Ed Engl· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multifunctional catalyst that stereoselectively assembles prodrugs.
Daniel A DiRocco, Yining Ji, Edward C Sherer, Artis Klapars, Mikhail Reibarkh, James Dropinski

Science· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods.
Peter S Kutchukian, James F Dropinski, Kevin D Dykstra, Bing Li, Daniel A DiRocco

Chem Sci· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs.
Libo Xu, Amy K Farthing, James F Dropinski, Peter T Meinke, Christine McCallum

Bioorg Med Chem Lett· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides.
Libo Xu, Amy K Farthing, James F Dropinski, Peter T Meinke, Christine McCallum

Bioorg Med Chem Lett· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARgamma partial agonists.
James F Dropinski, Taro Akiyama, Monica Einstein, Bahanu Habulihaz, Tom Doebber

Bioorg Med Chem Lett· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and structure-activity relationship of podocarpic acid amides as liver X receptor agonists for potential treatment of atherosclerosis.
Weiguo Liu, Steve Chen, James Dropinski, Lawrence Colwell, Michael Robins

Bioorg Med Chem Lett· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 2,3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activity.
Guo Q Shi, James F Dropinski, Yong Zhang, Conrad Santini, Soumya P Sahoo

J Med Chem· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.
Sheo B Singh, John G Ondeyka, Weiguo Liu, Steve Chen, Tom S Chen, James Dropinski

Bioorg Med Chem Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a novel class of PPARalpha/gamma dual agonists with potent antihyperglycemic and lipid modulating activity.
Guo Q Shi, James F Dropinski, Brian M McKeever, Shihua Xu, Joseph W Becker

J Med Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis